Anxiolytic activity of pyridoindole derivatives SMe1EC2 and SMe1M2: behavioral analysis using rat model

Atack JR. (2003). Anxioselective compounds acting at the GABA(A) receptor benzodiazepine binding site. Curr Drug Targets CNS Neurol Disord 2(4): 213-232.Search in Google Scholar

Balonová T, Zeljenková D, Ďurišová M, Nosáľ R, Jakubovský J, Líška J, Štolc S. (1991). Reproductive toxicity studies with cis- (-)-2,3,4,4a,5,9b-hexahydro-2,8-dimethyl-1H-pyrido[4,3-b]indole dipalmitate in rats. Arzneimittelforschung 41(1): 5.Search in Google Scholar

Barkov NK. (1973). On the Mode of Carbidine Action. Farmocol. Toxicol 36(4): 154-157.Search in Google Scholar

Barnard EA, Skolnick P, Olsen RW, Mohler H, Sieghart W, Biggio G, Braestrup C, Bateson AN, Langer SZ. (1998). International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function. Pharmacol Rev 50(2): 291-313.Search in Google Scholar

Basile AS, Lippa AS, Skolnick P. (2004). Anxioselective anxiolytics: can less be more? Eur J Pharmacol 500(1-3): 441-51.10.1016/j.ejphar.2004.07.043Search in Google Scholar

Braestrup C and Squires RF. (1977). Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding. Proc Natl Acad Sci U S A 74(9): 3805-3809.Search in Google Scholar

Chalupa I, Blasko M, Benes L. (1993). In vitro micronucleus test of the cardioprotective agent stobadine. A genotoxicological study. Pharmazie 3: 206-207.Search in Google Scholar

Crestani F, Martin JR, Möhler H, Rudolph U. (2000). Mechanism of action of the hypnotic zolpidem in vivo. Br J Pharmacol 131(7): 1251-1254.Search in Google Scholar

Dubovický M, Ujházy E, Kovacovský P, Rychlík I, Jansák J. (1999). Evaluation of long-term administration of the antioxidant stobadine on exploratory behavior in rats of both genders. J Appl Toxicol 19(6): 431-436.Search in Google Scholar

Dubovický M, Ujházy E, Kovačovský P, Rychlík I, Kalnovičová T, Navarová J, Turčáni P, Durišová M, Gajdošík A. (1997a). Effect of long-term administration of stobadine on exploratory behaviour and on striatal levels of dopamine and serotonin in rats and their off spring. J Appl Toxicol. 17: 63-70.10.1002/(SICI)1099-1263(199701)17:1<63::AID-JAT396>3.0.CO;2-MSearch in Google Scholar

European Commission. (2005). Improving the mental health of the population: Towards a strategy on mental health for the European Union. Health & Consumer Protection. Brussels, COM(2005) 484: 30.Search in Google Scholar

Gajdošíková A, Ujházy E, Gajdošík A, Chalupa I, Blaško M, Tomášková A, Liška J, Dubovický M, Bauer V. (1995). Chronic toxicity and micronucleus assay of the new cardioprotective agent stobadine in rats. Arzneimittelforschnung 45(5): 531-536.Search in Google Scholar

Griebel G, Perrault G, Simiand J, Cohen C, Granger P, Decobert M, Françon D, Avenet P, Depoortere H, Tan S, Oblin A, Schoemaker H, Evanno Y, Sevrin M, George P, Scatton B. (2001). SL651498: an anxioselective compound with functional selectivity for alpha2- and alpha3-containing gamma-aminobutyric acid(A) (GABA(A)) receptors. J Pharmacol Exp The 298(2): 753-768.Search in Google Scholar

Griebel G, Perrault G, Simiand J, Cohen C, Granger P, Depoortere H, Françon D, Avenet P, Schoemaker H, Evanno Y, Sevrin M, George P, Scatton B. (2003). SL651498, a GABAA Receptor Agonist with Subtype-Selective Efficacy, as a Potential Treatment for Generalized Anxiety Disorder and Muscle Spasms. CNS Drug Reviews 9(1): 3-20.Search in Google Scholar

Horáková L and Štolc S. (1998). Antioxidant and pharmacodynamic effects of pyridoindole stobadin. In Gen. Pharmacol. 30(5): 789-799.Search in Google Scholar

Licata SC, Platt DM, Cook JM, Sarma PV, Griebel G, Rowlett JK. (2005). Contribution of GABAA receptor subtypes to the anxiolytic-like, motor, and discriminative stimulus effects of benzodiazepines: studies with the functionally selective ligand SL651498 [6-fluoro-9-methyl-2-phenyl-4-(pyrrolidin-1-yl-carbonyl)-2,9-dihydro-1H-pyridol[3,4-b]indol-1-one]. J Pharmacol Exp Ther 313(3): 1118-1125.Search in Google Scholar

Löw K, Crestani F, Keist R, Benke D, Brünig I, Benson JA, Fritschy JM, Rülicke T, Bluethmann H, Möhler H, Rudolph U. (2000). Molecular and neuronal substrate for the selective attenuation of anxiety. Science 290(5489): 131-134.Search in Google Scholar

Majerčík M, Babinská M, Ujházy E, Babulbvá A, Balónová T. (1984). Six month toxicity of DP 1031 in beagle dogs. Cs Fyziol 33:171Search in Google Scholar

Möhler H and Okada T. (1977). Benzodiazepine receptor: demonstration in the central nervous system. Science 198: 849-851.Search in Google Scholar

Rudolph U, Crestani F, Benke D, Brünig I, Benson JA, Fritschy JM, Martin JR, Bluethmann H, Möhler H. (1999). Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Nature 401(6755): 796-800.Search in Google Scholar

Sandford JJ, Argyropoulos SV, Nutt DJ. (2000). The psychobiology of anxiolytic drugs Part 1: basic neurobiology. Pharmacol Ther 88(3):197-212.Search in Google Scholar

Štolc S, Šnirc V, Gajdošíková A, Gajdošík A, Gáspárová Z, Ondrejičková O, Sotníková R, Viola A, Rapta P, Jariabka P, Syneková I, Vajdová M, Zacharová S, Nemček V, Krchnárová V. (2008). New pyridoindoles with antioxidant and neuroprotectve actions, in Trends in pharmacological research (Bauer V, ed) pp. 118-136, Institute of Experimental Pharmacology Bratislava.Search in Google Scholar

Wittchen HU and Hoyer J. (2001). Generalized anxiety disorder: nature and course. J Clin Psychiatry 62(11):15-19.Search in Google Scholar

Wittchen HU and Jacobi F. (2005). Size and burden of mental disorders in Europe - a critical review and appraisal of 27 studies. Eur Neurospsychopharmacol 15(4): 357-376.Search in Google Scholar

World Health Organization. (2001). The world health report 2001 - Mental Health: New Understanding, New Hope. WHO GenevaSearch in Google Scholar